Surgery Partners (SGRY) to Announce Quarterly Earnings on Monday

Surgery Partners (NASDAQ:SGRY) is expected to be issuing its Q2 2026 results before the market opens on Monday, August 10th. Analysts expect the company to post earnings of $0.0579 per share and revenue of $830.03 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Monday, August 10, 2026 at 8:30 AM ET.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, May 5th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.12. Surgery Partners had a positive return on equity of 1.04% and a negative net margin of 2.28%.The firm had revenue of $810.90 million during the quarter, compared to the consensus estimate of $797.69 million. During the same period in the prior year, the firm posted $0.04 earnings per share. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, analysts expect Surgery Partners to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Surgery Partners Stock Up 4.1%

Shares of SGRY stock opened at $15.53 on Friday. Surgery Partners has a 1 year low of $11.41 and a 1 year high of $24.10. The stock has a market cap of $2.03 billion, a PE ratio of -25.88, a price-to-earnings-growth ratio of 4.46 and a beta of 1.91. The business’s fifty day moving average is $15.43 and its 200-day moving average is $14.44. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.69 and a current ratio of 1.86.

Hedge Funds Weigh In On Surgery Partners

A number of institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Surgery Partners by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company’s stock worth $1,085,000 after buying an additional 2,015 shares during the period. Millennium Management LLC grew its stake in Surgery Partners by 1,253.7% during the 1st quarter. Millennium Management LLC now owns 202,274 shares of the company’s stock valued at $4,804,000 after acquiring an additional 219,806 shares in the last quarter. Empowered Funds LLC grew its stake in Surgery Partners by 11.0% during the 1st quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock valued at $305,000 after acquiring an additional 1,278 shares in the last quarter. Prudential Financial Inc. purchased a new position in shares of Surgery Partners during the 2nd quarter valued at $219,000. Finally, Invesco Ltd. raised its position in Surgery Partners by 7.4% during the second quarter. Invesco Ltd. now owns 1,683,311 shares of the company’s stock valued at $37,420,000 after acquiring an additional 115,627 shares in the last quarter.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on SGRY. Jefferies Financial Group restated a “buy” rating and issued a $17.00 price objective on shares of Surgery Partners in a report on Wednesday, May 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a research report on Tuesday, May 26th. Finally, Zacks Research upgraded shares of Surgery Partners from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $21.60.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.